Sun Pharma issues advisory to its distribution channel partners to be vigilant about counterfeit drugs: Peethaambaran Kunnathoor, Chennai Thursday, March 20, 2025, 08:00 Hrs [IST] ...
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. | Three ...
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...
The Print on MSN22m
How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the US ...
In New Jersey, new initiatives support investment and job growth in the artificial intelligence and film and digital media ...
Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...
Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...
Pharmaceutical Technology on MSN9d
Sun Pharma agrees to acquire Checkpoint TherapeuticsSun Pharmaceutical has agreed to acquire Checkpoint Therapeutics for an aggregate consideration of up to $355m upfront.
Mumbai: In a recent BSE filing, Sun Pharmaceutical Industries Limited has informed that TARO Pharmaceuticals Inc., a ...
(Nasdaq: CKPT) ("Checkpoint") today announced that they have entered into an agreement by which Sun Pharma will acquire ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback